EIF Board Chair published in The Conversation

The COVID-19 omicron variant has many people wondering if it could act as a vaccine of sorts, inoculating enough people to effectively bring about herd immunity. University of South Carolina School of Medicine Columbia professors Prakash Nagarkatti, Chair of the EPSCoR/IDeA Foundation Board, and Mitzi Nagarkatti wrote for The Conversation about immune response to COVID-19.